151 related articles for article (PubMed ID: 20307356)
1. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
[TBL] [Abstract][Full Text] [Related]
2. Endogenous protection against oxidative stress caused by cisplatin: role of superoxide dismutase.
González-García JA; Nevado J; García-Berrocal JR; Sánchez-Rodríguez C; Trinidad A; Sanz R; Ramírez-Camacho R
Acta Otolaryngol; 2010 Apr; 130(4):453-7. PubMed ID: 19883181
[TBL] [Abstract][Full Text] [Related]
3. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
[TBL] [Abstract][Full Text] [Related]
4. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
5. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
[TBL] [Abstract][Full Text] [Related]
6. HSP-70 as a nonspecific early marker in cisplatin ototoxicity.
Ramírez-Camacho R; Citores MJ; Trinidad A; Verdaguer JM; García-Berrocal JR; Marero AM; Puente A; González-García JA; Vargas JA
Acta Otolaryngol; 2007 Jun; 127(6):564-7. PubMed ID: 17503223
[TBL] [Abstract][Full Text] [Related]
7. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
8. The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear.
García-Berrocal JR; Nevado J; Ramírez-Camacho R; Sanz R; González-García JA; Sánchez-Rodríguez C; Cantos B; España P; Verdaguer JM; Trinidad Cabezas A
Br J Pharmacol; 2007 Dec; 152(7):1012-20. PubMed ID: 17906689
[TBL] [Abstract][Full Text] [Related]
9. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
[TBL] [Abstract][Full Text] [Related]
10. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
11. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY
Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519
[TBL] [Abstract][Full Text] [Related]
12. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system.
Rybak LP; Husain K; Evenson L; Morris C; Whitworth C; Somani SM
Pharmacol Toxicol; 1997 Oct; 81(4):173-9. PubMed ID: 9353848
[TBL] [Abstract][Full Text] [Related]
13. Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system.
Rybak LP; Husain K; Whitworth C; Somani SM
Toxicol Sci; 1999 Feb; 47(2):195-202. PubMed ID: 10220857
[TBL] [Abstract][Full Text] [Related]
14. Time response of carboplatin-induced hearing loss in rat.
Husain K; Scott B; Whitworth C; Rybak LP
Hear Res; 2004 May; 191(1-2):110-8. PubMed ID: 15109710
[TBL] [Abstract][Full Text] [Related]
15. Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model.
Okur E; Kilinc M; Yildirim I; Kilic MA; Tolun FI
Laryngoscope; 2007 Dec; 117(12):2183-6. PubMed ID: 17909450
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration.
Ramírez-Camacho R; Fernández DE; Verdaguer JM; Gómez MM; Trinidad A; García-Berrocal JR; Corvillo MA
Acta Otolaryngol; 2008 May; 128(5):505-9. PubMed ID: 18421602
[TBL] [Abstract][Full Text] [Related]
17. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
18. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition.
Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG
Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin ototoxicity to the rat inner ear: a role for HMG1 and iNOS.
Li G; Liu W; Frenz D
Neurotoxicology; 2006 Jan; 27(1):22-30. PubMed ID: 16125245
[TBL] [Abstract][Full Text] [Related]
20. [Expression of heat shock protein 70 mRNA in guinea pig cochlea with ototoxicity of gentamicin].
Ni YQ; Tang H; Fu WS
Sheng Li Xue Bao; 2005 Jun; 57(3):328-32. PubMed ID: 15968427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
